Summit Therapeutics Stock Price (NASDAQ:SMMT)

Add to My Stocks
$2.32 $0.01 (0.43%) SMMT stock closing price Sep 18, 2018 (Closing)
Prev Close* : $2.31
Market Cap:
$31.98M
Day Low: $2.25
52 Week Low: $1.94
Open: $2.31
Volume: -
Day High: $2.35
52 Week High: $15.90
Dividend:
0.00

Latest Stock Market News

Latest Articles

Summit Therapeutics News - From Partners

SMMT Stockcharts

View SMMT PE ratio, PS ratio stocks charts and compare with peers.
SMMT Chart
Note: Compare Summit Therapeutics stock price history with the index and industry peers.

Summit Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
0.96
PB ratio (
price to book ratio
)
4.85

Summit Therapeutics Returns

ROE
(return on equity)
-169%

Summit Therapeutics Financial Ratios

Asset Turnover
0.27
Receivables Turnover
2.26
Debt to Equity
0
Dividend Yield
0%

SMMT Industry Peers

Company Price Change (%)
Isoray (ISR)0.570.04 (7.55%)
Kitov Pharma (KTOV)1.680.25 (12.95%)
Jaguar Health (JAGX)0.560.01 (1.82%)
Can-fite Biopharma (CANF)1.330.05 (3.91%)
Shire (SHPG)178.151.84 (1.04%)
Eisai (ESALY)95.832.74 (2.94%)
Zoetis (ZTS)89.180.88 (1%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

Summit Therapeutics PLC (ADR) Stock News - Partner Headlines

Summit Therapeutics Financial Statements

income statement2018201720162015
Net Sales or Revenues33.08M3.08M--
Net Income-9.28M-28.59M-26.01M-18.59M
Total Operating Expense49.76M36.32M30.71M20.8M
View Summit Therapeutics income statement
balance sheet2018201720162015
Total Assets70.22M50.28M38.18M31.74M
Total Liabilities57.37M54.96M6M7.25M
Shareholders Equity12.85M-4.67M32.17M24.49M
View Summit Therapeutics balance sheet
cash flow statement2018201720162015
Net Increase (Decrease) in Assets Liabilities-10.54M42.58M--0.54M
Net Cash from (used by) Operating Activities-19.11M16.24M-26.16M-18.53M
Increase (Decrease) in Prop Plant And Equipment-0.46M-0.1M-0.1M-0.05M
View Summit Therapeutics cash flow statement

Summit Therapeutics Stock Message Board

Summit Therapeutics stock price ended the last trading day at $2.32. Summit Therapeutics market capitalization is $31.98M and it represents the total market value of SMMT stock. Summit Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Summit Therapeutics is worth a lot, it will most likely be reflected in an inflated Summit Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 63,914 on the last trading day, as is evident from Summit Therapeutics stock chart, and SMMT stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Summit Therapeutics dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Summit Therapeutics stock price history.